Gary Bora
Papers
1
Total Citations
7
H-Index
1
About
Gary Bora is a rising investigator in the field of drug metabolism and toxicology, with a focused expertise in developing innovative high-throughput screening platforms. His most notable contribution is the design of a novel multiplexed assay that enables the rapid, simultaneous profiling of selective inhibitors for drug-metabolizing enzymes directly within human hepatocytes. This work, published in 2024 and already garnering 7 citations, addresses a critical bottleneck in early-stage drug discovery by providing a more physiologically relevant and efficient method to predict drug-drug interactions and metabolic liabilities. By moving beyond traditional recombinant enzyme systems, Bora’s approach offers a powerful tool for de-risking candidate compounds, potentially accelerating the development of safer therapeutics. His research sits at the intersection of assay miniaturization, cellular pharmacology, and ADME (absorption, distribution, metabolism, and excretion) science. As a young scientist, Bora’s early impact signals a promising trajectory in translational pharmacology, where his work is already being recognized for its practical utility in streamlining preclinical safety assessments.
Research Focus
Key Achievements
Top Papers
- 1